Skip to content

Ironwood Pharmaceuticals IRWD Collaborative Arrangements Linzess — Selling General And Administrative Expense

Similar metrics at other companies

Avanos Medical logo
AVNSSelling General And Administrative Expense
$77.7M+2.6%
Belden logo
BDCSelling General And Administrative Expense
$138.65M+5.4%
Ashland logo
ASHLife Sciences — Selling General And Administrative Expense
$20M+5.3%
United States Lime & Minerals, Inc. logo
USLMLime And Limestone Operations — Selling General And Administrative Expense
$5.97M-4.7%
Thermo Fisher Scientific logo
TMOLife Sciences Solutions — Selling, general and administrative expenses
$496M+6.0%
Landstar System logo
LSTRTransportation Logistics — Selling General And Administrative Expense
$57.79M-2.8%

Other financials

Income statement

See full
Revenue$106.5M+159%
Operating income$72.6M+349%
Net income$40.8M+209%
EPS (diluted)$0.24+204%

Balance sheet

See full
Cash & equivalents$220.5M+103%
Total debt$212.4M+1,323%
Total equity-$217.1M+35.0%
Total assets$434.6M+32.8%

Cash flow

See full
Operating cash flow$5.1M-74.3%
CapEx-
Free cash flow$74.6M+390%

Valuation

See full
Market cap$632.12M+457%
Enterprise value$624M+3,024%
P/E6.2×
P/S1.8×+1.4×

Profitability

See full
Gross margin99.2%
Operating margin55.4%+38.7pp
Net margin28.3%+22.3pp
FCF margin24.7%-11.1pp

Returns & leverage

See full
Return on equity29.7%-138pp
Debt / equity-0.5×
Current ratio1.4×-1.9×

Where this comes from

Reported directly by Ironwood Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ironwood Pharmaceuticals's collaborative arrangements linzess — selling general and administrative expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ironwood Pharmaceuticals's collaborative arrangements linzess — selling general and administrative expense?
Ironwood Pharmaceuticals (IRWD) reported collaborative arrangements linzess — selling general and administrative expense of $300K in Q1 2026.
How has Ironwood Pharmaceuticals's collaborative arrangements linzess — selling general and administrative expense changed year-over-year?
Ironwood Pharmaceuticals's collaborative arrangements linzess — selling general and administrative expense decreased by 90.3% year-over-year, from $3.1M to $300K.
What is the long-term trend for Ironwood Pharmaceuticals's collaborative arrangements linzess — selling general and administrative expense?
Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's collaborative arrangements linzess — selling general and administrative expense has grown at a -38.3% compound annual growth rate (CAGR), from $30.3M to $4.4M.
What does collaborative arrangements linzess — selling general and administrative expense mean?
This metric captures the operating costs associated with the selling, general, and administrative functions specifically allocated to the collaborative arrangement. It includes expenses related to overhead, administrative support, and general business operations required to maintain the partnership. Monitoring this helps assess the operational efficiency and cost management of the collaborative segment.